Torezolid
From Self-sufficiency
Revision as of 00:35, 31 March 2010 by حسن علي البط (Talk) (Adding category Category:Organofluorides (using HotCat))
| File:Torezolid.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
(5R)-3-{3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl]phenyl}-5-(hydroxymethyl)-1,3-oxazolidin-2-one | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 856866-72-3 |
| ATC code | none |
| ChemSpider | 9409096 |
| Chemical data | |
| Formula | C17H15FN6O3 |
| Molar mass | 370.338 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Torezolid (also known as TR-701) is an oxazolidinone drug in phase-II clinical trials for complicated skin and skin-structure infections (cSSSI), including those caused by Methicillin-resistant Staphylococcus aureus (MRSA).[1]
The prodrug is called "TR-701", while the active ingredient is called "TR-700".[2][3]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />| 50px | This systemic antibacterial-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Antibiotic stubs
- 2Fix
- Oxazolidinone antibiotics
- Tetrazoles
- Pyridines
- Organofluorides
